doi:10.3969/j.issn.1671-2587.2022.04.009

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2022, Vol. 24 ›› Issue (4): 454-458.DOI: 10.3969/j.issn.1671-2587.2022.04.009

Previous Articles Next Articles

Received:2021-10-22 Online:2022-08-20 Published:2022-08-19

[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] WANG H,MEN P X,XIAO Y F,et al.Hepatitis B infection in the general population of China:a systematic review and meta-analysis[J]. BMC Infect Dis,2019,19(1):811.
[3] LELIE N,VERMEULEN M,VAN DRIMMELEN H,et al.Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters[J].Vox Sang,2020,115(3):133-145.
[4] BUSCH M P,GLYNN S A,STRAMER S L,et al.A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors[J].Transfusion,2005,45(2):254-264.
[5] WEUSTEN J,VERMEULEN M,VAN DRIMMELEN H,et al.Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms[J]. Transfusion,2011,51(1):203-215.
[6] STRAMER S L,NOTARI E P,KRYSZTOF D E,et al.Hepatitis B virus testing by minipool nucleic acid testing:does it improve blood safety?[J]. Transfusion,2013,53(10 Pt 2):2449-2458.
[7] DODD R Y,CROWDER L A,HAYNES J M,et al.Screening blood donors for HIV,HCV,and HBV at the American red cross:10-year trends in prevalence,incidence,and residual risk,2007 to 2016[J]. Transfus Med Rev,2020,34(2):81-93.
[8] WHO technical report series; no.1004.WHO Expert Committee on Biological Standardization[S].Geneva: World Health Organization,2017,163-196.
[9] MIMMS L T,MOSLEY J W,HOLLINGER F B,et al.Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection[J]. BMJ,1993,307(6912):1095-1097.
[10] SABER H R,TABATABAEE S M,ABASIAN A,et al.Incidence and residual risk of HIV,HBV and HCV infections among blood donors in Tehran[J].Indian J Hematol Blood Transfus,2017,33(3):412-416.
[11] KLEINMAN S,BUSCH M P,KORELITZ J J,et al.The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection[J]. Transfus Med Rev,1997,11(3):155-172.
[12] SEED C R,CHENG A,ISMAY S L,et al.Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT[J]. Transfusion,2002,42(10):1365-1372.
[13] ZOU S M,STRAMER S L,NOTARI E P,et al.Current incidence and residual risk of hepatitis B infection among blood donors in the United States[J]. Transfusion,2009,49(8):1609-1620.
[14] SEED C R,KIELY P,KELLER A J.Residual risk of transfusion transmitted human immunodeficiency virus,hepatitis B virus,hepatitis C virus and human T lymphotrophic virus[J].Intern Med J,2005,35(10):592-598.
[15] SEED C R,KIELY P,HOAD V C,et al.Refining the risk estimate for transfusion-transmission of occult hepatitis B virus[J]. Vox Sang,2017,112(1):3-8.
[16] 余鼎,段艳,张燕,等. 两种数学模型用于重复供血浆人群丙型肝炎病毒及人类免疫缺陷病毒残余风险评估的比较[J]. 中国生物制品学杂志,2017,30(11):1220-1222.
[17] LI L,HAN T T,ZANG L,et al.The Current incidence,prevalence,and residual risk of hepatitis B viral infections among voluntary blood donors in China[J]. BMC Infect Dis,2017,17(1):754.
[18] 何子毅,陈庆恺,陈少彬,等.四种血液安全筛查模式对经血传播病毒残余风险的评估[J].中国输血杂志,2018,31(2):140-143.
[19] SHANG G F,SEED C R,WANG F,et al.Residual risk of transfusion-transmitted viral infections in Shenzhen,China,2001 through 2004[J]. Transfusion,2007,47(3):529-539.
[20] ZOU S M,FANG C T,DODD R Y.On residual risk assessment for first-time donation[J]. Transfusion,2007,47(12):2348.
[21] BUSCH M P,GLYNN S A,STRAMER S L,et al.A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors[J]. Transfusion,2005,45(2):254-264.
[22] WEN X,SU H,WANG Y,et al.Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City,Gansu Province,China[J]. J Viral Hepat,2018,25(3):281-288.
[23] CORRÊA A,LAMARÃO L M,VIEIRA P C M,et al. Prevalence,incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil[J]. PLoS One,2018,13(12):e0208414.
[24] SCHEIBLAUER H,HEIDEN M,FUNK M,et al.Detecti on of hepatitis B virus infection in German blood donors 2008-2015[J].Vox Sang,2020,115(3):152-161.
[25] 尹湧华,孔玉洁,王美玉,等. 《血站技术操作规程(2015版)》研读[J]. 中国输血杂志,2016,29(11):1303-1305.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	PAN Xue, SONG Ying-Wei, LIN Jie, et al. Effects of Preoperative Anemia on Perioperative Blood Transfusion and Clinical Outcomes in Patients Undergoing Orthopedic Surgery [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 409-415.
[2]	ZHOU Lin, CI Xuan, SHAO Xiao-bao, et al. Correlation between Perioperative Blood Transfusion and Postoperative Inflammatory Complications in Patients with Colorectal Cancer [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 416-421.
[3]	LI Xiao-fei, ZHANG Ye, LIU Ting-ting, et al. Research of Ael Subgroup Gene Polymorphism [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 422-426.
[4]	FAN Ke-xin, ZHU Peng-hui, WANG Yun, et al. The Prediction Model of Fetomaternal Hemorrhage was Established on Machine Learning Algorithm [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 427-432.
[5]	QUAN Jun-hui, ZHANG Ming-gang, WU Jiao-jiao, et al. Exploring the Serological Characteristics of Cells with Different Rh Phenotypes Bounded an anti-CD47 McAb, TJC4 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 432-437.
[6]	WANG Shuai, LI Jun. Analyze the Influencing Factors and Alloimmunization on Rh（CcEe）in Patients with Liver Cirrhosis after ABO, Rh（D） Isotype Random Matched Blood Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 443-447.
[7]	LI Yan-hui, SHI Lin-ying, ZHOU Mou, et al. Experimental Study on Core Performance Test of the Heating and Pressurizing Blood Transfusion Apparatus [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 448-454.
[8]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 507-511.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 511-514.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 518-520.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 521-527.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 528-532.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 273-278.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 279-284.
[15]	YI Xing, YUAN Xiao-hua, BAI Lin, et al. Practical Experience of COVID-19 Convalescent Plasma Collection,Preparation and Distribution by 38 Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 285-290.